Sam Stevens: How Common Sense Oncology Can Help to Make a Tangible Difference in the Pacific Region

At Least 40 Hours of Nutrition Education in Medical Schools - Kennedy and McMahon

Jérôme Salomon: History of Preventive Medicine

Miriam Mutebi: Inspiring the Next Generation of Women Surgeons in Africa

Newly Diagnosed AML: 2026 Treatment Algorithms - Resonance

Oncology News, Insights, Stories by OncoDaily

CancerWorld
Voices

CancerWorld Issue #113 (March) is Live!

Princess Dina Mired
Voices

Princess Dina Mired: Nurses at the Heart of Childhood Cancer Care

OncoDaily weekly
Not To Miss

Oncology This Two Weeks: OncoDaily Weekly Feb 23 – March 8, 2026

CHOPIN Trial: Percutaneous Hepatic Perfusion Plus Ipilimumab and Nivolumab in Metastatic Uveal Melanoma

Servier Partners with Women in Tech to Support 5 Million Women in STEM

Cristian Massacesi: SUCCESSOR-2 Phase 3 in Relapsed/Refractory MM

Celebrating Women Driving Global Cancer Progress - UICC

10 Must-Read Posts In GI Oncology This Week

MiNK Therapeutics Announced a Collaboration With C-Further - Jennifer Buell

Ruiling Yuan: The Power of Women Supporting and Elevating Each Other

Cervical Cancer 2026
Advances in The Immunotherapy of Cold Tumors
Advances in The Immunotherapy of Cold Tumors
OncoThon 2026
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Agenus

$20M Zydus Collaboration: Support for BOT and BAL Manufacturing - Agenus

Tedros Adhanom Ghebreyesus Recognizes SAGE’s Role in Protecting Millions Through Vaccines

Chinmay Jani: Precision Oncology Insights from Healthcare Business Conference 2026

Karamvir Yadav: Thromboembolism in Cancer Trials, Underestimated Risk

Matthew Oberley: Clonal Hematopoiesis and IO Therapy Response

Evis Sala: Advancing Social Welfare and Gender Equality Reforms in Albania

Major Step to Simplify Biosimilar Medicines - U.S. FDA 

FDA Approvals
FDA approval BRAFTOVI

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Reliable leukemia subtyping with machine learning and conformal prediction? - Resonance

Resonance

27 Mar
leukemia

25th Annual International Congress on the Future of Breast Cancer East

Physicians’ Education Resource

10 Jul
Breast Cancer

25th Annual International Congress on the Future of Breast Cancer West

Physicians’ Education Resource

17 Jul
Breast Cancer

10th Annual Live Medical Crossfire: Hematologic Malignancies

Physicians’ Education Resource

11 Jul
Hematologic Malignancies

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

Physicians’ Education Resource

02 Oct
Gastrointestinal Oncology

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

OncoDaily TV
Accelerating Cancer Immunotherapy: Parker Institute & ASCO Launch Young Investigator Award

Accelerating Cancer Immunotherapy: Parker Institute & ASCO Launch Young Investigator Award

They Said It Would Never Work — Dr. George Demetri and the Drug That Changed GIST Forever

They Said It Would Never Work — Dr. George Demetri and the Drug That Changed GIST Forever

Empowering Oncologists

Empowering Oncologists: How service and volunteering advances one’s career?

ACT for Children: How Armenia is Changing Pediatric Oncology | Dr. Jennifer Lowe

ACT for Children: How Armenia is Changing Pediatric Oncology | Dr. Jennifer Lowe

When a Cancer Surgeon Becomes Minister of Health | Dr. Jigjidsuren Chinburen

When a Cancer Surgeon Becomes Minister of Health | Dr. Jigjidsuren Chinburen

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

What’s Next for Cancer Care in Armenia? Scott Howard

What’s Next for Cancer Care in Armenia? Scott Howard

The Breast Friends Podcast

Why Hasn’t Immunotherapy Consistently Delivered in HER2+ Disease? – The Breast Friends

Childhood Cancer

Saving One Million Children: WHO’s Global Initiative for Childhood Cancer with Dr. Catherine Lam

Jeffrey Bluestone

Inside the Mind of Jeffrey Bluestone: Lessons From a Lifetime in Immunology

Princess Dina Mired and Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Not To Miss
ESMO Congress 2026 - OncoDaily

Meet the Scientific Co-Chairs of the ESMO Congress 2026

OncoGrants Weekly: Top 10 OncoGrants to Apply for in 2026: Deadlines from March to June

International Women’s Day Highlights 2026: Honoring Women in Oncology

Oncology This Two Weeks: OncoDaily Weekly Feb 23 – March 8, 2026

HPV Awareness Day 2026: Why It Matters More Than Ever

15 Posts Not To Miss From 50th Simeonideios Lecture

15 Posts Not To Miss from ESGO 2026

OncoGrants
Melanoma Research Foundation (MRF) Established Investigator Award 2026

Melanoma Research Foundation (MRF) Established Investigator Award 2026

V Foundation V Scholar Grant 2026 (Adult Cancer — General Competition)

V Foundation V Scholar Grant 2026 (Adult Cancer — General Competition)

V Foundation Pediatric Cancer Research Awards 2026 (V Scholar + Translational + All-Star)

V Foundation Pediatric Cancer Research Awards 2026 (V Scholar + Translational + All-Star)

Conquer Cancer Young Investigator Award in Chronic Lymphocytic Leukemia 2026

Conquer Cancer Young Investigator Award in Chronic Lymphocytic Leukemia 2026

Conquer Cancer Young Investigator Award in Primary Brain Tumors 2026

Conquer Cancer Young Investigator Award in Primary Brain Tumors 2026

American Cancer Society Discovery Boost Grant (DBG)

American Cancer Society Discovery Boost Grant (DBG)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Ruzanna Papyan

Ruzanna Papyan

Oncologists Location Yerevan, Armenia
LIdia Schapira

Lidia Schapira

Oncologists Location Stanford, USA
Florian Lordick

Florian Lordick

Oncologists Location Leipzig, Germany
Yelena Janjigian

Yelena Janjigian

Oncologists Location New York, USA
Sarkis Meterissian

Sarkis Meterissian

Oncologists Location Montreal, Canada
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

Oncologists Location São Paulo, Brazil
Ana Filipa Martins Ferreira Varges Gomes

Ana Filipa Martins Ferreira Varges Gomes

Oncologists Location Portimão, Portugal
Karima Oualla

Karima Oualla

Oncologists Location Fès, Morocco

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
Neoadjuvant GOLP

Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma: ZSAB-neoGOLP Trial

Sentinel Lymph Node Biospy

Sentinel Node Biopsy for Melanoma: Survival Benefit Confirmed in a Large Meta-Analysis

CAPItello-281 Trial

CAPItello-281 Trial at ASCO GU : Capivasertib Plus Abiraterone in PTEN-Deficient mHSPC

BCG

BCG and Beyond: Is Systemic Immunotherapy Progress or Overreach in BCG-Naïve NMIBC?

Rezatapopt

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts